Mark Crowther: How Artificial Intelligence Is Entering The Field of Hematology
Mark Crowther, Distinguished University Professor and Chair, Department of Medicine at McMaster University, shared on LinkedIn:
”Fair Warning: This One Is for the Hematologists… Mostly.
If your day does not typically involve peripheral smears, coagulation assays, or bone marrow biopsies, this may feel a bit niche.
But stay with me.
A recent article in The Hematologist from the American Society of Hematology examines how artificial intelligence is entering the field of hematology — and while the examples are specialty-specific, the implications are much broader.
AI is already influencing how we:
- Interpret laboratory data and digital morphology
- Analyze large-scale genomic and clinical datasets
- Synthesize literature and draft documentation
- Predict outcomes and support risk stratification
Hematology is a useful case study.
It is data-rich, image-heavy, and highly quantitative — an ideal testing ground for algorithmic tools.
But the core questions apply across medicine, engineering, education, and health systems:
- How do we validate these tools before adoption?
- How do we recognize and mitigate embedded bias?
- How do we train professionals to use AI critically rather than passively?
- Where does accountability sit when machines assist decision-making?
At institutions like McMaster University, these are not abstract issues.
They are central to our broader AI agenda — integrating innovation while preserving rigor, transparency, and professional judgment.
So yes — this post may disproportionately excite hematologists.
But the conversation is much larger than one specialty.
AI will not replace expertise. It will reshape how expertise is exercised.”
Title: Artificial Intelligence and Hematology: What’s Promising Today and What Will Impact Practice Tomorrow?
Authors: Vanessa Kennedy, Lori Muffly
Read the Full Article on The Hematologist

Stay updated on all scientific advances with Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS